Concentrix slides after $1.05 billion impairment charge drives Q3 loss
Concentrix shares fell 11.5% to $22.02 premarket after a $1.05 billion non-cash goodwill impairment led to a Q3 loss of $16.24 per share. Q3 revenue was $2.45 billion vs $2.48 billion estimates; adj. EPS was $2.92 vs $2.71 estimates.
Concentrix shares fell 11.5% to $22.02 in premarket trading after the company reported a $16.24 per share loss in the third quarter, driven by a $1.05 billion non-cash goodwill impairment charge. Revenue for the quarter came in at $2.45 billion, below estimates of $2.48 billion, while adjusted earnings per share of $2.92 topped the $2.71 forecast. LSEG data showed the stock trading at 2.23 times expected earnings over the next 12 months, versus an industry median of 13.72. Of 6 brokerages covering the stock, 3 rate it buy or higher and 3 rate it hold; the median target price is $30.
As of the last close, CNXC was down 40.16% year to date.